share_log

Argus Research Maintains Buy on United Therapeutics, Lowers Price Target to $280

Benzinga ·  Apr 21, 2023 09:23

Argus Research analyst Jasper Hellweg maintains United Therapeutics (NASDAQ:UTHR) with a Buy and lowers the price target from $300 to $280.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment